+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharmacovigilance and Drug Safety Software - Global Strategic Business Report

  • PDF Icon

    Report

  • 197 Pages
  • February 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140073

Global Pharmacovigilance and Drug Safety Software Market to Reach $289.5 Million by 2030

The global market for Pharmacovigilance and Drug Safety Software estimated at US$183 Million in the year 2022, is projected to reach a revised size of US$289.5 Million by 2030, growing at a CAGR of 5.9% over the analysis period 2022-2030. ADR Reporting, one of the segments analyzed in the report, is projected to record 5.5% CAGR and reach US$132.7 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Drug Safety Audits segment is readjusted to a revised 6.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $54.2 Million, While China is Forecast to Grow at 5.5% CAGR

The Pharmacovigilance and Drug Safety Software market in the U.S. is estimated at US$54.2 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$50.5 Million by the year 2030 trailing a CAGR of 5.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 47 Featured) -

  • AB Cube
  • ArisGlobal LLC
  • Ennov USA
  • Extedo GmbH
  • Online Business Applications, Inc.
  • Oracle Corporation
  • Sarjen Systems Pvt. Ltd.
  • Sparta Systems, Inc.
  • United Biosource Corporation

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Pharmacovigilance and Drug Safety Software

What is the estimated value of the Global Market for Pharmacovigilance and Drug Safety Software?

The Global Market for Pharmacovigilance and Drug Safety Software was estimated to be valued at $183 Million in 2022.

What is the growth rate of the Global Market for Pharmacovigilance and Drug Safety Software?

The growth rate of the Global Market for Pharmacovigilance and Drug Safety Software is 5.9%, with an estimated value of $289.5 Million by 2030.

What is the forecasted size of the Global Market for Pharmacovigilance and Drug Safety Software?

The Global Market for Pharmacovigilance and Drug Safety Software is estimated to be worth $289.5 Million by 2030.

Who are the key companies in the Global Market for Pharmacovigilance and Drug Safety Software?

Key companies in the Global Market for Pharmacovigilance and Drug Safety Software include AB Cube, ArisGlobal LLC, Ennov USA, Extedo GmbH, Online Business Applications, Inc., Oracle Corporation, Sarjen Systems Pvt. Ltd., Sparta Systems, Inc. and United Biosource Corporation.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Pharmacovigilance and Drug Safety Software - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for ADR Reporting by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for ADR Reporting by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Drug Safety Audits by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Drug Safety Audits by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Issue Tracking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Issue Tracking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Fully Integrated Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Fully Integrated Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 12: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for BPOs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 14: World 8-Year Perspective for BPOs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 16: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 17: World Pharmacovigilance and Drug Safety Software Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • Table 18: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 19: World 8-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 21: World 8-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Contract Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 23: World 8-Year Perspective for Contract Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 24: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 25: USA 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 26: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 29: USA 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • CANADA
  • Table 30: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 34: Canada Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 35: Canada 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • JAPAN
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 36: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 37: Japan 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 38: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 39: Japan 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 40: Japan Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 41: Japan 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • CHINA
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 42: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 43: China 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 44: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 45: China 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 46: China Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 47: China 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • EUROPE
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 48: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2022 through 2030 and % CAGR
  • Table 49: Europe 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 50: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 51: Europe 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 52: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 53: Europe 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 54: Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 55: Europe 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • FRANCE
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 56: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 57: France 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 58: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 59: France 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 60: France Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 61: France 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • GERMANY
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 62: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 63: Germany 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 64: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 65: Germany 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 66: Germany Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 67: Germany 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • ITALY
  • Table 68: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 69: Italy 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 70: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 71: Italy 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 72: Italy Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 73: Italy 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • UNITED KINGDOM
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 74: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 75: UK 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 76: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 77: UK 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 78: UK Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 79: UK 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • REST OF EUROPE
  • Table 80: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 81: Rest of Europe 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 82: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 83: Rest of Europe 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 84: Rest of Europe Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 85: Rest of Europe 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • ASIA-PACIFIC
  • Pharmacovigilance and Drug Safety Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 86: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 87: Asia-Pacific 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 88: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 89: Asia-Pacific 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 90: Asia-Pacific Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 91: Asia-Pacific 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
  • REST OF WORLD
  • Table 92: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Functionality - ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 93: Rest of World 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Functionality - Percentage Breakdown of Value Sales for ADR Reporting, Drug Safety Audits, Issue Tracking and Fully Integrated Software for the Years 2023 & 2030
  • Table 94: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by End-Use - Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 95: Rest of World 8-Year Perspective for Pharmacovigilance and Drug Safety Software by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Contract Research Organizations, BPOs and Other End-Uses for the Years 2023 & 2030
  • Table 96: Rest of World Recent Past, Current & Future Analysis for Pharmacovigilance and Drug Safety Software by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ for the Years 2022 through 2030 and % CAGR
  • Table 97: Rest of World 8-Year Perspective for Pharmacovigilance and Drug Safety Software by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • AB Cube
  • ArisGlobal LLC
  • Ennov USA
  • Extedo GmbH
  • Online Business Applications, Inc.
  • Oracle Corporation
  • Sarjen Systems Pvt. Ltd.
  • Sparta Systems, Inc.
  • United Biosource Corporation